|
MRPL53 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.964600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.149690E-02 |
| Normal-vs-Stage2 |
1.401440E-01 |
| Normal-vs-Stage3 |
2.998100E-02 |
| Normal-vs-Stage4 |
3.888100E-02 |
| Stage1-vs-Stage2 |
9.019400E-01 |
| Stage1-vs-Stage3 |
9.114600E-01 |
| Stage1-vs-Stage4 |
9.854000E-01 |
| Stage2-vs-Stage3 |
9.659000E-01 |
| Stage2-vs-Stage4 |
9.250800E-01 |
| Stage3-vs-Stage4 |
9.385400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.210100E-02 |
| Normal-vs-AfricanAmerican |
8.172600E-04 |
| Normal-vs-Asian |
7.045000E-01 |
| Caucasian-vs-AfricanAmerican |
1.343950E-02 |
| Caucasian-vs-Asian |
9.264600E-01 |
| AfricanAmerican-vs-Asian |
3.285600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.729600E-02 |
| Normal-vs-Female |
2.449100E-04 |
| Male-vs-Female |
7.824400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.089400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.380000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.332130E-02 |
| Normal-vs-Age(81-100Yrs) |
2.451700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.034000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.834600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.345400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.172200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.612170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.842160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.195600E-03 |
| Normal-vs-Grade 2 |
1.868390E-02 |
| Normal-vs-Grade 3 |
1.959800E-02 |
| Normal-vs-Grade 4 |
5.646200E-02 |
| Grade 1-vs-Grade 2 |
1.314370E-01 |
| Grade 1-vs-Grade 3 |
8.783900E-02 |
| Grade 1-vs-Grade 4 |
1.420620E-01 |
| Grade 2-vs-Grade 3 |
9.336600E-01 |
| Grade 2-vs-Grade 4 |
9.442800E-01 |
| Grade 3-vs-Grade 4 |
8.904200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.397900E-02 |
| Normal-vs-ccB subtype |
8.091600E-01 |
| ccA subtype-vs-ccB subtype |
4.558100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.590000E-02 |
| Normal-vs-N1 |
2.403600E-01 |
| N0-vs-N1 |
9.760600E-01 |
|
|
